Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Vitamin A nasal spray being trialled for COVID smell loss

September 29, 2021 Research and Development

The University of East Anglia is conducting a 12-week trial to investigate the use of vitamin A nasal spray to …
News

Several rival companies set to launch antiviral pills for COVID-19

September 29, 2021 Research and Development

With Merck and Pfizer preparing to release clinical trial results from its experimental COVID-19 antiviral pills, rivals are lining up …
News

Eisai launch bid for accelerated FDA approval for new Alzheimer’s drug

September 28, 2021 Manufacturing and Production, Medical Communications, Research and Development

Japanese drug maker Eisai has launched a bid for accelerated FDA approval for its new experimental drug for early Alzheimer’s …
News
white-46040b7c-9161-4bd9-82b0-b36120519a07_1_1

Children in India to receive COVID-19 vaccine from October

September 22, 2021 Research and Development

  All Indian children aged 12 or older will become eligible for their COVID-19 vaccinations from next month, in the …
News
christianschetter

Dr. Christian Schetter hired as Chief Scientific Officer at Rentschler Biopharma

September 22, 2021 Research and Development

Rentschler Biopharma has announced the appointment of Dr. Christian Schetter as their new CSO. In this position, Schetter will be …
Appointment

HCA Healthcare to become one of MPT’s top tenants

September 22, 2021 Research and Development

Medical Properties Trust (MPT) and HCA Healthcare have agreed to a 15-year master lease for hospitals representing $1.2 billion of …
News

CHMP recommends GSK’s Nucala (mepolizumab) for three eosinophil-driven diseases

September 22, 2021 Research and Development

  GlaxoSmithKline (GSK) has announced that the Committee for Medicinal Products for Human Use (CHMP) has issued positive feedback on …
News

Novartis champion advanced breast cancer survival data at ESMO 2021

September 22, 2021 Research and Development

Novartis has presented captivating new data in advanced breast cancer, which championed the longest ever reported median overall survival, as …
News

University of Edinburgh partners with Cancer Research UK to build startup companies

September 22, 2021 Research and Development

The University of Edinburgh’s Venture Builder Incubator, a business support programme, has partnered with Cancer Research UK to help build …
News

Government report finds serious overprescription issues in England

September 22, 2021 Medical Communications, Research and Development

A government report has found serious overprescription issues in England, with 10% of items dispensed in primary care being overprescribed, …
News

J&J: Second COVID shot boosts effectiveness by 94%

September 22, 2021 Medical Communications, Research and Development

Johnson & Johnson have released data showing that a second dose of their one shot COVID-19 vaccine boosts protection from …
News

FDA: Accelerated approval for Genmab and Seagen’s TIVDAK

September 21, 2021 Manufacturing and Production, Research and Development

The FDA has granted accelerated approval for Genmab and Seagen’s TIVDAK (tisotumab vedotin-tftv), the first and only approved antibody-drug conjugate …
News

Singapore scientists turn discarded fruit peel into antibacterial bandages

September 20, 2021 Research and Development, Sales and Marketing

Scientists at Nanyang Technological University (NTU) in Singapore have created antibacterial organo-hydrogel bandages from discarded durian peel.The process extracts cellulose …
News

Cambodian bat researchers aiming to find COVID-19 origin

September 20, 2021 Research and Development, Sales and Marketing

An eight-member Institut Pasteur du Cambodge (IPC) research team has been collecting samples from bats in an attempt to discover …
News

NICE recommends MSD’s Keytruda for oesophageal cancer patients

September 17, 2021 Medical Communications, Research and Development

NICE has approved the use of pembrolizumab – MSD’s checkpoint inhibitor immunotherapy – in combination with platinum- and fluoropyrimidine-based chemotherapy, …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026